Futura Medical plc (FAMDF)

Market Cap	32.54M
Revenue (ttm)	17.43M
Net Income (ttm)	1.62M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	20.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,000
Average Volume	6,477
Open	0.0500
Previous Close	0.0700
Day's Range	0.0500 - 0.1300
52-Week Range	0.0100 - 0.6000
Beta	0.83
RSI	38.38
Earnings Date	Jun 10, 2025

About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: FAMDF

Financial Performance

Financial numbers in GBP